Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Add To Watchlist

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

PR Newswire August 7, 2018

ANI Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference

PR Newswire August 6, 2018

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2018 Financial Results

PR Newswire August 1, 2018

ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP

PR Newswire June 27, 2018

Market Trends Toward New Normal in EnviroStar, Rowan Companies, Del Taco Restaurants, ANI Pharmaceuticals, Infinity Property and Casualty, and Viacom — Emerging Consolidated Expectations, Analyst Ratings

GlobeNewswire June 25, 2018

ANI Shareholders Elect Three New Members to the Board of Directors

PR Newswire June 5, 2018

ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance

PR Newswire May 8, 2018

ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax

PR Newswire May 7, 2018

ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2018 Financial Results

PR Newswire May 1, 2018

Amneal And Impax Receive FTC Clearance For Business Combination

PR Newswire April 27, 2018

ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax

PR Newswire April 27, 2018

ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution

PR Newswire April 18, 2018

ANI Acquires 23 ANDAs from IDT Australia, Ltd.

PR Newswire April 4, 2018

Detailed Research: Economic Perspectives on Lear, MYOS RENS Technology, Dollar Tree, Halliburton, Waters, and ANI Pharmaceuticals — What Drives Growth in Today's Competitive Landscape

GlobeNewswire March 5, 2018

ANI Pharmaceuticals to Present at the Raymond James 39th Annual Institutional Investors Conference

PR Newswire March 2, 2018

ANI Pharmaceuticals, Inc. to Host Earnings Call

Accesswire February 27, 2018

ANI Pharmaceuticals Reports Record Full Year Results, Reports Fourth Quarter 2017 Results, and Provides 2018 Guidance

PR Newswire February 27, 2018

ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results and 2018 Guidance

PR Newswire February 20, 2018

ANI Pharmaceuticals Enters Five-Year $125 Million Senior Secured Credit Facility with Citizens Bank

PR Newswire December 29, 2017

ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million

PR Newswire December 29, 2017